Targeting convergent mechanisms of castration resistant prostate cancer therapy resistance, metastasis, and immune evasion with AR-LDDs
Research Grant
Administered By
Medicine, Medical Oncology
Awarded By
Celgene Corporation
Start Date
September 3, 2019
End Date
September 3, 2024
Administered By
Medicine, Medical Oncology
Awarded By
Celgene Corporation
Start Date
September 3, 2019
End Date
September 3, 2024